{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:37:39Z","timestamp":1790635059218,"version":"4.1.0"},"reference-count":220,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Heilongjiang Touyan Innovation Team Program, China","award":["[2019] No.5"],"award-info":[{"award-number":["[2019] No.5"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), the leading chronic liver condition globally, constitutes a major etiological contributor to hepatocellular carcinoma (HCC). Its transition from steatosis to non-alcoholic steatohepatitis (NASH) involves progressive fibrosis, ultimately predisposing to HCC. The pathogenesis involves multifactorial interactions among genetic susceptibility, environmental triggers, and obesity-associated metabolic dysregulation. Crucially, the gut\u2013liver axis serves as a pivotal regulatory mechanism in MASLD development. Current therapeutic strategies prioritize lifestyle interventions for metabolic syndrome management, while pharmacological options remain limited, underscoring the need for new therapies. Emerging evidence highlights phenolic acids\u2014bioactive phytochemicals from medicinal plants\u2014as multi-target agents against MASLD. These compounds demonstrate therapeutic efficacy via antioxidative modulation of stress, anti-inflammatory activity, and gut\u2013liver axis regulation. This review synthesizes recent advances in natural phenolic acids for MASLD intervention, emphasizing their potential as preventive and therapeutic candidates. Their multimodal mechanisms may inform innovative drug development paradigms targeting MASLD pathogenesis.<\/jats:p>","DOI":"10.3390\/antiox14070760","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T06:10:27Z","timestamp":1750399827000},"page":"760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Regulatory Mechanisms of Phenolic Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Shengyu","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Shen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Di","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7234-1135","authenticated-orcid":false,"given":"Feng","family":"Guan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: Definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Calzadilla Bertot, L., and Adams, L.A. (2016). The Natural Course of Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050774"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: How is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Boccatonda, A., Andreetto, L., D\u2019Ardes, D., Cocco, G., Rossi, I., Vicari, S., Schiavone, C., Cipollone, F., and Guagnano, M.T. (2023). From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030883"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20420188221145549","DOI":"10.1177\/20420188221145549","article-title":"MAFLD: A multisystem disease","volume":"14","author":"Pipitone","year":"2023","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_8","first-page":"2097435","article-title":"Nonalcoholic Fatty Liver Disease","volume":"2018","author":"Forbes","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Xie, C., and Halegoua-DeMarzio, D. (2019). Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?. Nutrients, 11.","DOI":"10.3390\/nu11112837"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wang, B., Jiang, X., Cao, M., Ge, J., Bao, Q., Tang, L., Chen, Y., and Li, L. (2016). Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease. Sci. Rep., 6.","DOI":"10.1038\/srep32002"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","article-title":"Gut\u2013liver axis, nutrition, and non-alcoholic fatty liver disease","volume":"48","author":"Kirpich","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","article-title":"Intestinal microbiome and NAFLD: Molecular insights and therapeutic perspectives","volume":"55","author":"Hu","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.gastro.2014.12.004","article-title":"Herbal Products and the Liver: A Review of Adverse Effects and Mechanisms","volume":"148","author":"Seeff","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nutres.2018.11.002","article-title":"Chlorogenic acid attenuates high-carbohydrate, high-fat diet\u2013induced cardiovascular, liver, and metabolic changes in rats","volume":"62","author":"Bhandarkar","year":"2019","journal-title":"Nutr. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1002\/fsn3.4178","article-title":"Polyphenols improve non-alcoholic fatty liver disease via gut microbiota: A comprehensive review","volume":"12","author":"Mohammadhasani","year":"2024","journal-title":"Food Sci. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrendo.2017.173","article-title":"Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus","volume":"14","author":"Targher","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101231","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: From pathophysiology towards diagnostic and therapeutic strategies","volume":"95","author":"Parola","year":"2024","journal-title":"Mol. Asp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xiao, Z., Liu, M., Yang, F., Liu, G., Liu, J., Zhao, W., Ma, S., and Duan, Z. (2023). Programmed cell death and lipid metabolism of macrophages in NAFLD. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1118449"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"G949","DOI":"10.1152\/ajpgi.00215.2003","article-title":"Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration","volume":"285","author":"Schwabe","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.actbio.2015.06.028","article-title":"Designing a fibrotic microenvironment to investigate changes in human liver sinusoidal endothelial cell function","volume":"24","author":"Ford","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21833","DOI":"10.3390\/ijms141121833","article-title":"Rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"14","author":"Imajo","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wainwright, P., and Byrne, C.D. (2016). Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030367"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis","volume":"15","author":"Kheong","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1080\/1028415X.2021.1926140","article-title":"Fucoxanthin has potential for therapeutic efficacy in neurodegenerative disorders by acting on multiple targets","volume":"25","author":"Yang","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14209","article-title":"CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients","volume":"39","author":"Pockros","year":"2019","journal-title":"Liver Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2021.10.018","article-title":"EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study","volume":"76","author":"Ratziu","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jhep.2022.10.023","article-title":"Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH","volume":"78","author":"Ratziu","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1210\/jc.2018-01446","article-title":"Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial","volume":"103","author":"Braun","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Podszun, M.C., Alawad, A.S., Lingala, S., Morris, N., Huang, W.A., Yang, S., Schoenfeld, M., Rolt, A., Ouwerkerk, R., and Valdez, K. (2020). Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis. Redox Biol., 37.","DOI":"10.1016\/j.redox.2020.101710"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.cgh.2023.01.018","article-title":"Saroglitazar, a Dual PPAR \u03b1\/\u03b3 Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis","volume":"21","author":"Siddiqui","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2036.2008.03869.x","article-title":"Clinical trial: Pilot study of metformin for the treatment of non-alcoholic steatohepatitis","volume":"29","author":"Loomba","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Arze","year":"2019","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Di Lorenzo, C., Colombo, F., Biella, S., Stockley, C., and Restani, P. (2021). Polyphenols and Human Health: The Role of Bioavailability. Nutrients, 13.","DOI":"10.3390\/nu13010273"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Shabalala, S.C., Dludla, P.V., Mabasa, L., Kappo, A.P., Basson, A.K., Pheiffer, C., and Johnson, R. (2020). The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomed. Pharmacother., 131.","DOI":"10.1016\/j.biopha.2020.110785"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kumar, N., and Goel, N. (2019). Phenolic acids: Natural versatile molecules with promising therapeutic applications. Biotechnol. Rep., 24.","DOI":"10.1016\/j.btre.2019.e00370"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3390\/molecules14062202","article-title":"Phenolics: From Chemistry to Biology","volume":"14","author":"Pereira","year":"2009","journal-title":"Molecules"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"111732","DOI":"10.1016\/j.foodres.2022.111732","article-title":"Noni (Morinda citrifolia L.) fruit phenolic extract supplementation ameliorates NAFLD by modulating insulin resistance, oxidative stress, inflammation, liver metabolism and gut microbiota","volume":"160","author":"Wang","year":"2022","journal-title":"Food Res. Int."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sun, M., Zhang, Z., Xie, J., Yu, J., Xiong, S., Xiang, F., Ma, X., Yang, C., and Lin, L. (2024). Research Progress on the Mechanism for Improving Glucose and Lipid Metabolism Disorders Using Phenolic Acid Components from Medicinal and Edible Homologous Plants. Molecules, 29.","DOI":"10.3390\/molecules29204790"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sova, M., and Saso, L. (2020). Natural Sources, Pharmacokinetics, Biological Activities and Health Benefits of Hydroxycinnamic Acids and Their Metabolites. Nutrients, 12.","DOI":"10.3390\/nu12082190"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e10467","DOI":"10.1016\/j.heliyon.2022.e10467","article-title":"Structure-antiradical activity relationships of 25 natural antioxidant phenolic compounds from different classes","volume":"8","author":"Moazzen","year":"2022","journal-title":"Heliyon"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Vega, A., Delgado, N., and Handford, M. (2022). Increasing Heavy Metal Tolerance by the Exogenous Application of Organic Acids. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105438"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Xie, J., Xiong, S., Li, Y., Xia, B., Li, M., Zhang, Z., Shi, Z., Peng, Q., Li, C., and Lin, L. (2024). Phenolic acids from medicinal and edible homologous plants: A potential anti-inflammatory agent for inflammatory diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1345002"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1007\/s13197-014-1488-2","article-title":"Anti-obesity and cardioprotective effects of cinnamic acid in high fat diet- induced obese rats","volume":"52","author":"Mnafgui","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"ref_52","first-page":"5747","article-title":"Unraveling the mechanisms of trans-cinnamic acid in ameliorating non-alcoholic fatty liver disease","volume":"15","author":"Solanki","year":"2023","journal-title":"Am. J. Transl. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9561613","DOI":"10.1155\/2021\/9561613","article-title":"Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation","volume":"2021","author":"Wu","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Wu, Y., Wang, M.H., Yang, T., Qin, T.Y., Qin, L.L., Hu, Y.M., Zhang, C.F., Sun, B.J., Ding, L., and Wu, L.L. (2021). Mechanisms for Improving Hepatic Glucolipid Metabolism by Cinnamic Acid and Cinnamic Aldehyde: An Insight Provided by Multi-Omics. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.794841"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Nie, W., Yang, Y., Li, L., Ding, Y., Chen, X., Li, M., He, N., Ji, G., Zhang, Y., and Kang, P. (2023). Comparison of pharmacokinetic profiles of seven major bioactive components in normal and non-alcoholic fatty liver disease (NAFLD) rats after oral administration of Ling-Gui-Zhu-Gan decoction by UPLC-MS\/MS. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1174742"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4292\/wjgpt.v14.i2.4","article-title":"Cinnamic acid regulates the intestinal microbiome and short-chain fatty acids to treat slow transit constipation","volume":"14","author":"Jiang","year":"2023","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fct.2018.08.060","article-title":"Protective effects of p-coumaric acid against acetaminophen-induced hepatotoxicity in mice","volume":"121","author":"Cha","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"ref_58","first-page":"164","article-title":"p-Coumaric acid has pure anti-inflammatory characteristics against hepatopathy caused by ischemia-reperfusion in the liver and dust exposure","volume":"26","author":"Moradi","year":"2023","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Goodarzi, G., Tehrani, S.S., Panahi, G., Bahramzadeh, A., and Meshkani, R. (2023). Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL\/6 mice. J. Nutr. Biochem., 118.","DOI":"10.1016\/j.jnutbio.2023.109369"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"116988","DOI":"10.1016\/j.jep.2023.116988","article-title":"The identification of material basis of Si Miao Formula effective for attenuating non-alcoholic fatty liver disease","volume":"318","author":"Li","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Yuan, Z., Lu, X., Lei, F., Sun, H., Jiang, J., Xing, D., and Du, L. (2023). Novel Effect of p-Coumaric Acid on Hepatic Lipolysis: Inhibition of Hepatic Lipid-Droplets. Molecules, 28.","DOI":"10.3390\/molecules28124641"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3181\/0901-RM-1","article-title":"Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice","volume":"234","author":"Ye","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"31790","DOI":"10.18632\/oncotarget.9306","article-title":"Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Or\u0161oli\u0107, N., Sirovina, D., Odeh, D., Gajski, G., Balta, V., \u0160ver, L., and Jazvin\u0161\u0107ak Jembrek, M. (2021). Efficacy of Caffeic Acid on Diabetes and Its Complications in the Mouse. Molecules, 26.","DOI":"10.3390\/molecules26113262"},{"key":"ref_65","first-page":"4205","article-title":"Ferulic acid attenuated acetaminophen-induced hepatotoxicity though down-regulating the cytochrome P 2E1 and inhibiting toll-like receptor 4 signaling-mediated inflammation in mice","volume":"8","author":"Yuan","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.3390\/nu7085283","article-title":"Ferulic Acid Alleviates Changes in a Rat Model of Metabolic Syndrome Induced by High-Carbohydrate, High-Fat Diet","volume":"7","author":"Senaphan","year":"2015","journal-title":"Nutrients"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Liang, Y., Qi, J., Yu, D., Wang, Z., Li, W., Long, F., Ning, S., Yuan, M., and Zhong, X. (2024). Ferulic Acid Alleviates Lipid and Bile Acid Metabolism Disorders by Targeting FASN and CYP7A1 in Iron Overload-Treated Mice. Antioxidants, 13.","DOI":"10.3390\/antiox13111277"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/cns.14060","article-title":"Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4\/NF-\u03baB pathway","volume":"29","author":"Zhang","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1007\/s00394-022-02927-7","article-title":"Ferulic acid improves intestinal barrier function through altering gut microbiota composition in high-fat diet-induced mice","volume":"61","author":"Tian","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Luo, Z., Li, M., Yang, J., Li, J., Zhang, Y., Liu, F., El-Omar, E., Han, L., Bian, J., and Gong, L. (2022). Ferulic acid attenuates high-fat diet-induced hypercholesterolemia by activating classic bile acid synthesis pathway. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.976638"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Luo, Z., Li, M., Yang, Q., Zhang, Y., Liu, F., Gong, L., Han, L., and Wang, M. (2022). Ferulic Acid Prevents Nonalcoholic Fatty Liver Disease by Promoting Fatty Acid Oxidation and Energy Expenditure in C57BL\/6 Mice Fed a High-Fat Diet. Nutrients, 14.","DOI":"10.3390\/nu14122530"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"He, S., Liu, F., Xu, L., Yin, P., Li, D., Mei, C., Jiang, L., Ma, Y., and Xu, J. (2016). Protective Effects of Ferulic Acid against Heat Stress-Induced Intestinal Epithelial Barrier Dysfunction In Vitro and In Vivo. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0145236"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Gu, X., Wei, M., Hu, F., Ouyang, H., Huang, Z., Lu, B., and Ji, L. (2023). Chlorogenic acid ameliorated non-alcoholic steatohepatitis via alleviating hepatic inflammation initiated by LPS\/TLR4\/MyD88 signaling pathway. Chem. Biol. Interact., 376.","DOI":"10.1016\/j.cbi.2023.110461"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jnutbio.2018.06.005","article-title":"Chlorogenic acid improves intestinal barrier functions by suppressing mucosa inflammation and improving antioxidant capacity in weaned pigs","volume":"59","author":"Chen","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3456542","DOI":"10.1155\/2021\/3456542","article-title":"Chlorogenic Acid Alleviates Colon Mucosal Damage Induced by a High-Fat Diet via Gut Microflora Adjustment to Increase Short-Chain Fatty Acid Accumulation in Rats","volume":"2021","author":"Xie","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2014.01.015","article-title":"Chlorogenic acid attenuates lipopolysaccharide-induced mice mastitis by suppressing TLR4-mediated NF-\u03baB signaling pathway","volume":"729","author":"Ruifeng","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Yan, Y., Zhou, X., Guo, K., Zhou, F., and Yang, H. (2020). Chlorogenic Acid Protects Against Indomethacin-Induced Inflammation and Mucosa Damage by Decreasing Bacteroides-Derived LPS. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01125"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"9381","DOI":"10.1021\/acs.jafc.3c00953","article-title":"Chlorogenic Acid Alleviates Chronic Stress-Induced Intestinal Damage by Inhibiting the P38MAPK\/NF-\u03baB Pathway","volume":"71","author":"Zhao","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1039\/D0FO03199B","article-title":"Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis","volume":"12","author":"Zhou","year":"2021","journal-title":"Food Funct."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1039\/D2FO00038E","article-title":"Moderation of gut microbiota and bile acid metabolism by chlorogenic acid improves high-fructose-induced salt-sensitive hypertension in mice","volume":"13","author":"Zhu","year":"2022","journal-title":"Food Funct."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Li, H., Xi, Y., Xin, X., Feng, Q., and Hu, Y. (2023). Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1148737"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e07465","DOI":"10.1016\/j.heliyon.2021.e07465","article-title":"Cinnamic acid ameliorate gentamicin-induced liver dysfunctions and nephrotoxicity in rats through induction of antioxidant activities","volume":"7","author":"Babaeenezhad","year":"2021","journal-title":"Heliyon"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.micres.2013.02.005","article-title":"Innate immune recognition of microbial cell wall components and microbial strategies to evade such recognitions","volume":"168","author":"Sukhithasri","year":"2013","journal-title":"Microbiol. Res."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Amarante-Mendes, G.P., Adjemian, S., Branco, L.M., Zanetti, L.C., Weinlich, R., and Bortoluci, K.R. (2018). Pattern Recognition Receptors and the Host Cell Death Molecular Machinery. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02379"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e0241","DOI":"10.1097\/HC9.0000000000000241","article-title":"Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD\/NASH, HCC, and beyond","volume":"7","author":"Ohtani","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Fianchi, F., Liguori, A., Gasbarrini, A., Grieco, A., and Miele, L. (2021). Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut\u2013Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126485"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/liv.15160","article-title":"Roles for the mycobiome in liver disease","volume":"42","author":"Zeng","year":"2022","journal-title":"Liver Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3920196","DOI":"10.1155\/2020\/3920196","article-title":"The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Ma\u0142odobra-Mazur, M., Lewo\u0144, D., Cierzniak, A., Okulus, M., and Gliszczy\u0144ska, A. (2021). Phospholipid Derivatives of Cinnamic Acid Restore Insulin Sensitivity in Insulin Resistance in 3T3-L1 Adipocytes. Nutrients, 13.","DOI":"10.3390\/nu13103619"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00281-022-00910-2","article-title":"TNF in the liver: Targeting a central player in inflammation","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jgr.2020.06.004","article-title":"p-coumaric acid, an active ingredient of Panax ginseng, ameliolates atopic dermatitis-like skin lesions through inhibition of thymic stromal lymphopoietin in mice","volume":"45","author":"Moon","year":"2021","journal-title":"J. Ginseng Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10068-022-01118-8","article-title":"Amelioration of radiation-induced liver damage by p-coumaric acid in mice","volume":"31","author":"Li","year":"2022","journal-title":"Food Sci. Biotechnol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Cao, B., Zeng, M.N., Hao, F.X., Hao, Z.Y., Zhang, Z.K., Liang, X.W., Wu, Y.Y., Zhang, Y.H., Feng, W.S., and Zheng, X.K. (2023). P-coumaric acid ameliorates A\u03b225\u201335-induced brain damage in mice by modulating gut microbiota and serum metabolites. Biomed. Pharmacother., 168.","DOI":"10.1016\/j.biopha.2023.115825"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/0115680266276823231230183519","article-title":"P-coumaric Acid: Advances in Pharmacological Research Based on Oxidative Stress","volume":"24","author":"Chen","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3214","article-title":"The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention","volume":"12","author":"Peters","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/hep.32012","article-title":"Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study","volume":"74","author":"Driessen","year":"2021","journal-title":"Hepatology"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Chen, J., Yang, J., Ma, L., Li, J., Shahzad, N., and Kim, C.K. (2020). Structure-antioxidant activity relationship of methoxy, phenolic hydroxyl, and carboxylic acid groups of phenolic acids. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-59451-z"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Or\u0161oli\u0107, N., Landeka Jur\u010devi\u0107, I., \u0110iki\u0107, D., Rogi\u0107, D., Odeh, D., Balta, V., Perak Junakovi\u0107, E., Terzi\u0107, S., and Jutri\u0107, D. (2019). Effect of Propolis on Diet-Induced Hyperlipidemia and Atherogenic Indices in Mice. Antioxidants, 8.","DOI":"10.3390\/antiox8060156"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Muhammad Abdul Kadar, N.N., Ahmad, F., Teoh, S.L., and Yahaya, M.F. (2021). Caffeic Acid on Metabolic Syndrome: A Review. Molecules, 26.","DOI":"10.3390\/molecules26185490"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Pavl\u00edkov\u00e1, N. (2022). Caffeic Acid and Diseases-Mechanisms of Action. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010588"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4239\/wjd.v14.i2.62","article-title":"Modulatory effect of caffeic acid in alleviating diabetes and associated complications","volume":"14","author":"Ganguly","year":"2023","journal-title":"World J. Diabetes"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2982.2012.01921.x","article-title":"Intestinal barrier function in health and gastrointestinal disease","volume":"24","author":"Camilleri","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","article-title":"Regulation of Intestinal Barrier Function by Microbial Metabolites","volume":"11","author":"Ghosh","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Di Tommaso, N., Santopaolo, F., Gasbarrini, A., and Ponziani, F.R. (2023). The Gut-Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021470"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/1873-3468.14328","article-title":"Lipopolysaccharide and the gut microbiota: Considering structural variation","volume":"596","author":"Mohr","year":"2022","journal-title":"FEBS Lett."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Candelli, M., Franza, L., Pignataro, G., Ojetti, V., Covino, M., Piccioni, A., Gasbarrini, A., and Franceschi, F. (2021). Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126242"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Mohammad, S., and Thiemermann, C. (2020). Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.594150"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Salvoza, N., Giraudi, P.J., Tiribelli, C., and Rosso, N. (2022). Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052764"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"9734816","DOI":"10.1155\/2016\/9734816","article-title":"Overview of the Role of Vanillin on Redox Status and Cancer Development","volume":"2016","author":"Bezerra","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Li, X., Wu, J., Xu, F., Chu, C., Li, X., Shi, X., Zheng, W., Wang, Z., Jia, Y., and Xiao, W. (2022). Use of Ferulic Acid in the Management of Diabetes Mellitus and Its Complications. Molecules, 27.","DOI":"10.3390\/molecules27186010"},{"key":"ref_112","first-page":"e68063","article-title":"Ferulic Acid: A Comprehensive Review","volume":"16","author":"Purushothaman","year":"2024","journal-title":"Cureus"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.trecan.2022.02.009","article-title":"The gut-liver axis: Host microbiota interactions shape hepatocarcinogenesis","volume":"8","author":"Silveira","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Fiorucci, S., Biagioli, M., Zampella, A., and Distrutti, E. (2018). Bile Acids Activated Receptors Regulate Innate Immunity. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01853"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"114291","DOI":"10.1016\/j.ejmech.2022.114291","article-title":"Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective","volume":"235","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s10787-023-01277-y","article-title":"Ferulic acid ameliorates ulcerative colitis in a rat model via the inhibition of two LPS-TLR4-NF-\u03baB and NF-\u03baB-INOS-NO signaling pathways and thus alleviating the inflammatory, oxidative and apoptotic conditions in the colon tissue","volume":"31","author":"Lorigooini","year":"2023","journal-title":"Inflammopharmacology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1620\/tjem.2023.J023","article-title":"Ferulic Acid Alleviates Hepatic Lipid Accumulation and Inflammation by Improving Proximal and Distal Intestinal Barriers in NAFLD Mice","volume":"260","author":"Fu","year":"2023","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Nemeth, E., and Ganz, T. (2021). Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126493"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e52280","DOI":"10.15252\/embr.202052280","article-title":"PPAR\u03b1 alleviates iron overload-induced ferroptosis in mouse liver","volume":"23","author":"Xing","year":"2022","journal-title":"EMBO Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.aninu.2021.08.004","article-title":"Ferulic acid mediates prebiotic responses of cereal-derived arabinoxylans on host health","volume":"9","author":"Zhang","year":"2022","journal-title":"Anim. Nutr."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Fhu, C.W., and Ali, A. (2020). Fatty Acid Synthase: An Emerging Target in Cancer. Molecules, 25.","DOI":"10.3390\/molecules25173935"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Yu Cai Lim, M., and Kiat Ho, H. (2024). Pharmacological modulation of cholesterol 7\u03b1-hydroxylase (CYP7A1) as a therapeutic strategy for hypercholesterolemia. Biochem. Pharmacol., 220.","DOI":"10.1016\/j.bcp.2023.115985"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","article-title":"Roles of PPARs in NAFLD: Potential therapeutic targets","volume":"1821","author":"Tailleux","year":"2012","journal-title":"BBA Mol. Cell Biol. Lipids"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.foodchem.2006.11.012","article-title":"Antioxidant activity of hydroxycinnamic acid derivatives in human low density lipoprotein: Mechanism and structure\u2013activity relationship","volume":"104","author":"Cheng","year":"2007","journal-title":"Food Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jphs.2021.05.006","article-title":"Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK\/NF-\u03baB signaling pathways","volume":"147","author":"Wei","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"101294","DOI":"10.1016\/j.tranon.2021.101294","article-title":"Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer","volume":"15","author":"Nwafor","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Liang, N., and Kitts, D.D. (2015). Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions. Nutrients, 8.","DOI":"10.3390\/nu8010016"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1570159X17666191021111809","article-title":"Pharmacologic Overview of Chlorogenic Acid and its Metabolites in Chronic Pain and Inflammation","volume":"18","author":"Bagdas","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/13880209.2018.1527370","article-title":"In vivo protective effects of chlorogenic acid against triptolide-induced hepatotoxicity and its mechanism","volume":"56","author":"Wang","year":"2018","journal-title":"Pharm. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): Structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e0127","DOI":"10.1097\/HC9.0000000000000127","article-title":"FXR and NASH: An avenue for tissue-specific regulation","volume":"7","author":"Henry","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"100344","DOI":"10.1016\/j.jhepr.2021.100344","article-title":"Ablation of liver Fxr results in an increased colonic mucus barrier in mice","volume":"3","author":"Ijssennagger","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"Finan","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Bernsmeier, C., Meyer-Gerspach, A.C., Blaser, L.S., Jeker, L., Steinert, R.E., Heim, M.H., and Beglinger, C. (2014). Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087488"},{"key":"ref_137","first-page":"97","article-title":"Gut microbiota is a factor of risk for obesity and type 2 diabetes","volume":"92","author":"Demidova","year":"2020","journal-title":"Ter. Arkh."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., and Li, X. (2020). Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176356"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1007\/s12035-022-03005-z","article-title":"Chlorogenic Acid: A Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson\u2019s Disease by GLP-1 Secretion","volume":"59","author":"Sharma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Yanagimoto, A., Matsui, Y., Yamaguchi, T., Hibi, M., Kobayashi, S., and Osaki, N. (2022). Effects of Ingesting Both Catechins and Chlorogenic Acids on Glucose, Incretin, and Insulin Sensitivity in Healthy Men: A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial. Nutrients, 14.","DOI":"10.3390\/nu14235063"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1210\/er.2009-0030","article-title":"Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk","volume":"31","author":"Manco","year":"2010","journal-title":"Endocr. Rev."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"eabe1692","DOI":"10.1126\/scitranslmed.abe1692","article-title":"Hepatocyte TLR4 triggers inter-hepatocyte Jagged1\/Notch signaling to determine NASH-induced fibrosis","volume":"13","author":"Yu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Shi, A., Li, T., Zheng, Y., Song, Y., Wang, H., Wang, N., Dong, L., and Shi, H. (2021). Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.693048"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"102623","DOI":"10.1016\/j.psj.2023.102623","article-title":"Effects of dietary chlorogenic acid on intestinal barrier function and the inflammatory response in broilers during lipopolysaccharide-induced immune stress","volume":"102","author":"Tan","year":"2023","journal-title":"Poult. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Chen, J., Zhou, Z., Wu, N., Li, J., Xi, N., Xu, M., Wu, F., Fu, Q., Yan, G., and Liu, Y. (2024). Chlorogenic acid attenuates deoxynivalenol-induced apoptosis and pyroptosis in human keratinocytes via activating Nrf2\/HO-1 and inhibiting MAPK\/NF-\u03baB\/NLRP3 pathways. Biomed. Pharmacother., 170.","DOI":"10.1016\/j.biopha.2023.116003"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1039\/C8FO01126E","article-title":"Dietary chlorogenic acid supplementation affects gut morphology, antioxidant capacity and intestinal selected bacterial populations in weaned piglets","volume":"9","author":"Zhang","year":"2018","journal-title":"Food Funct."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1039\/D1FO02662C","article-title":"Chlorogenic acid improves the intestinal barrier by relieving endoplasmic reticulum stress and inhibiting ROCK\/MLCK signaling pathways","volume":"13","author":"Song","year":"2022","journal-title":"Food Funct."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/01480545.2018.1523187","article-title":"Protocatechuic acid protects against menadione-induced liver damage by up-regulating nuclear erythroid-related factor 2","volume":"43","author":"Ibitoye","year":"2020","journal-title":"Drug Chem. Toxicol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.crfs.2022.01.006","article-title":"Protocatechuic acid protects hepatocytes against hydrogen peroxide-induced oxidative stress","volume":"5","author":"Lee","year":"2022","journal-title":"Curr. Res. Food Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1111\/bph.15159","article-title":"Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease","volume":"177","author":"Sun","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/21691401.2020.1776307","article-title":"Protocatechuic acid inhibits proliferation, migration and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes","volume":"48","author":"Wu","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Munkong, N., Somnuk, S., Jantarach, N., Ruxsanawet, K., Nuntaboon, P., Kanjoo, V., and Yoysungnoen, B. (2023). Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice. Nutrients, 15.","DOI":"10.3390\/nu15010246"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2238959","DOI":"10.1080\/19490976.2023.2238959","article-title":"Protection against Metabolic Associated Fatty Liver Disease by Protocatechuic Acid","volume":"15","author":"Tan","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_156","first-page":"218","article-title":"Protocatechuic Acid Protects Mice Against Non-Alcoholic Fatty Liver Disease by Attenuating Oxidative Stress and Improving Lipid Profile","volume":"13","author":"Khorsandi","year":"2024","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.sjbs.2020.12.023","article-title":"Protective effect of vanillic acid in hydrogen peroxide-induced oxidative stress in D.Mel-2 cell line","volume":"28","author":"Taqvi","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Ziadlou, R., Barbero, A., Martin, I., Wang, X., Qin, L., Alini, M., and Grad, S. (2020). Anti-Inflammatory and Chondroprotective Effects of Vanillic Acid and Epimedin C in Human Osteoarthritic Chondrocytes. Biomolecules, 10.","DOI":"10.3390\/biom10060932"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"9946","DOI":"10.3390\/nu7125514","article-title":"Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats","volume":"7","author":"Chang","year":"2015","journal-title":"Nutrients"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1556\/2060.2021.00188","article-title":"Effect of vanillic acid and exercise training on fatty liver and insulin resistance in rats: Possible role of fibroblast growth factor 21 and autophagy","volume":"108","author":"Obydah","year":"2021","journal-title":"Physiol. Int."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Qin, L., Tan, J., Lv, X., and Zhang, J. (2023). Vanillic acid alleviates liver fibrosis through inhibiting autophagy in hepatic stellate cells via the MIF\/CD74 signaling pathway. Biomed. Pharmacother., 168.","DOI":"10.1016\/j.biopha.2023.115673"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.aninu.2021.06.009","article-title":"Dietary ferulic acid and vanillic acid on inflammation, gut barrier function and growth performance in lipopolysaccharide-challenged piglets","volume":"8","author":"Hu","year":"2022","journal-title":"Anim. Nutr."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"107128","DOI":"10.1016\/j.phrs.2024.107128","article-title":"Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9\/STIM1-mediated ferroptosis","volume":"202","author":"Ni","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.intimp.2018.11.049","article-title":"Gallic acid improved inflammation via NF-\u03baB pathway in TNBS-induced ulcerative colitis","volume":"67","author":"Zhu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Sato, A., Kishimoto, Y., Mabashi-Asazuma, H., Kondo, K., and Iida, K. (2020). Gallic Acid Inhibits Lipid Accumulation via AMPK Pathway and Suppresses Apoptosis and Macrophage-Mediated Inflammation in Hepatocytes. Nutrients, 12.","DOI":"10.3390\/nu12051479"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"154589","DOI":"10.1016\/j.phymed.2022.154589","article-title":"Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function","volume":"109","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Zhang, D., Zhou, Q., Yang, X., Zhang, Z., Wang, D., Hu, D., Huang, Y., Sheng, J., and Wang, X. (2024). Gallic Acid Can Promote Low-Density Lipoprotein Uptake in HepG2 Cells via Increasing Low-Density Lipoprotein Receptor Accumulation. Molecules, 29.","DOI":"10.3390\/molecules29091999"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"952943","DOI":"10.1155\/2014\/952943","article-title":"A review on protocatechuic Acid and its pharmacological potential","volume":"2014","author":"Kakkar","year":"2014","journal-title":"ISRN Pharmacol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"6139308","DOI":"10.1155\/2021\/6139308","article-title":"Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/BJ20100791","article-title":"Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation","volume":"433","author":"Kendrick","year":"2011","journal-title":"Biochem. J."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/nar\/gkr1251","article-title":"The food additive vanillic acid controls transgene expression in mammalian cells and mice","volume":"40","author":"Gitzinger","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Amin, F.U., Shah, S.A., and Kim, M.O. (2017). Vanillic acid attenuates A\u03b2(1\u201342)-induced oxidative stress and cognitive impairment in mice. Sci. Rep., 7.","DOI":"10.1038\/srep40753"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.2174\/1381612827666210701145438","article-title":"Vanillic Acid and Non-Alcoholic Fatty Liver Disease: A Focus on AMPK in Adipose and Liver Tissues","volume":"27","author":"Shekari","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.2019002907","article-title":"Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Dovale-Rosabal, G., Espinosa, A., Rodr\u00edguez, A., Barriga, A., Palomino-Calder\u00f3n, A., Romero, N., Troncoso, R.H., and Aubourg, S.P. (2022). Effect of Structured Phenolic Lipids with EPA\/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice. Molecules, 27.","DOI":"10.3390\/molecules27227702"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Chao, J., Cheng, H.Y., Chang, M.L., Huang, S.S., Liao, J.W., Cheng, Y.C., Peng, W.H., and Pao, L.H. (2020). Gallic Acid Ameliorated Impaired Lipid Homeostasis in a Mouse Model of High-Fat Diet-and Streptozotocin-Induced NAFLD and Diabetes through Improvement of \u03b2-oxidation and Ketogenesis. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.606759"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Chao, J., Huo, T.I., Cheng, H.Y., Tsai, J.C., Liao, J.W., Lee, M.S., Qin, X.M., Hsieh, M.T., Pao, L.H., and Peng, W.H. (2014). Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096969"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI27300","article-title":"Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2","volume":"116","author":"Savage","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2174\/0929867324666170404142450","article-title":"Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products","volume":"25","author":"Gang","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Choung, S., Kim, J.M., Joung, K.H., Lee, E.S., Kim, H.J., and Ku, B.J. (2019). Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210828"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.18632\/oncotarget.6799","article-title":"Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Bai, J., Zhang, Y., Tang, C., Hou, Y., Ai, X., Chen, X., Zhang, Y., Wang, X., and Meng, X. (2021). Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomed. Pharmacother., 133.","DOI":"10.1016\/j.biopha.2020.110985"},{"key":"ref_183","first-page":"527","article-title":"Gallic acid protects the liver against NAFLD induced by dust exposure and high-fat diet through inhibiting oxidative stress and repressing the inflammatory signaling pathways NF-k\u03b2\/TNF-\u03b1\/IL-6 in Wistar rats","volume":"11","author":"Fanaei","year":"2021","journal-title":"Avicenna J. Phytomed."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11101-009-9145-5","article-title":"Bioavailability of hydroxycinnamates: A brief review of in vivo and in vitro studies","volume":"9","author":"Zhao","year":"2010","journal-title":"Phytochem. Rev."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/jf035366k","article-title":"Intestinal absorption of p-coumaric and gallic acids in rats after oral administration","volume":"52","author":"Konishi","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jf0478307","article-title":"Pharmacokinetic study of caffeic and rosmarinic acids in rats after oral administration","volume":"53","author":"Konishi","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4314\/tjpr.v15i2.20","article-title":"Pharmacokinetics of caffeic acid from methanol seed extract of Syzygium cumini L in rats","volume":"15","author":"Islam","year":"2016","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Zhang, C., Ma, W., Zhang, Y., Wang, Q., Qin, C., Du, S., Huang, L., Ye, F., Chen, L., and Zheng, T. (2018). Pharmacokinetics, Bioavailability, and Tissue Distribution Study of Angoroside C and Its Metabolite Ferulic Acid in Rat Using UPLC-MS\/MS. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01186"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Cadena-I\u00f1iguez, J., Santiago-Osorio, E., S\u00e1nchez-Flores, N., Salazar-Aguilar, S., Soto-Hern\u00e1ndez, R.M., Riviello-Flores, M.L., Mac\u00edas-Zaragoza, V.M., and Agui\u00f1iga-S\u00e1nchez, I. (2024). The Cancer-Protective Potential of Protocatechuic Acid: A Narrative Review. Molecules, 29.","DOI":"10.3390\/molecules29071439"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1021\/acschemneuro.5b00051","article-title":"Fate of microbial metabolites of dietary polyphenols in rats: Is the brain their target destination?","volume":"6","author":"Gasperotti","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2017.04.033","article-title":"The gut microbiota: A key factor in the therapeutic effects of (poly)phenols","volume":"139","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.foodchem.2014.10.057","article-title":"Bioactivity of phenolic acids: Metabolites versus parent compounds: A review","volume":"173","author":"Heleno","year":"2015","journal-title":"Food Chem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.fct.2013.12.024","article-title":"Ferulic acid: Pharmacological and toxicological aspects","volume":"65","author":"Mancuso","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1111\/bph.12676","article-title":"The pharmacokinetics of anthocyanins and their metabolites in humans","volume":"171","author":"Czank","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1021\/jf035407c","article-title":"Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal caco-2 cell monolayers","volume":"52","author":"Konishi","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.eclnm.2007.08.003","article-title":"Vanillic acid excretion can be used to assess compliance with dietary supplements","volume":"2","author":"Sayavongsa","year":"2007","journal-title":"E-SPEN Eur. E-J. Clin. Nutr. Metab."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.1021\/jf301807g","article-title":"Biosynthesis, natural sources, dietary intake, pharmacokinetic properties, and biological activities of hydroxycinnamic acids","volume":"60","author":"Khalifa","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e02708","DOI":"10.1016\/j.heliyon.2019.e02708","article-title":"Urinary excretion rate and bioavailability of chlorogenic acid, caffeic acid, p-coumaric acid, and ferulic acid in non-fasted rats maintained under physiological conditions","volume":"5","author":"Kishida","year":"2019","journal-title":"Heliyon"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3109\/13880209.2013.879906","article-title":"Bioavailability of caffeic acid in rats and its absorption properties in the Caco-2 cell model","volume":"52","author":"Wang","year":"2014","journal-title":"Pharm. Biol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"6179427","DOI":"10.1155\/2018\/6179427","article-title":"Isopropyl Caffeate: A Caffeic Acid Derivative-Antioxidant Potential and Toxicity","volume":"2018","author":"Lira","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"3957262","DOI":"10.1155\/2018\/3957262","article-title":"An Overview on the Anti-inflammatory Potential and Antioxidant Profile of Eugenol","volume":"2018","author":"Barboza","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jat.2550040602","article-title":"The occurrence, metabolism and toxicity of cinnamic acid and related compounds","volume":"4","author":"Hoskins","year":"1984","journal-title":"J. Appl. Toxicol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"S645","DOI":"10.4103\/pm.pm_389_16","article-title":"Cinnamaldehyde, Cinnamic Acid, and Cinnamyl Alcohol, the Bioactives of Cinnamomum cassia Exhibit HDAC8 Inhibitory Activity: An In vitro and In silico Study","volume":"13","author":"Patil","year":"2017","journal-title":"Pharmacogn. Mag."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1002\/jsfa.7578","article-title":"p-Coumaric acid and its conjugates: Dietary sources, pharmacokinetic properties and biological activities","volume":"96","author":"Pei","year":"2016","journal-title":"J. Sci. Food Agric."},{"key":"ref_205","first-page":"1","article-title":"Acute toxicity of caffeic acid in mice and rats","volume":"70","author":"Moridani","year":"1994","journal-title":"Toxicol. Lett."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.fct.2018.10.040","article-title":"Reproductive and developmental toxicity study of caffeic acid in mice","volume":"123","author":"Liu","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"119921","DOI":"10.1016\/j.lfs.2021.119921","article-title":"Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives","volume":"284","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.clnu.2011.11.003","article-title":"Ferulic acid is nephrodamaging while gallic acid is renal protective in long term treatment of chronic kidney disease","volume":"31","author":"Peng","year":"2012","journal-title":"Clin. Nutr."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Liu, B., Cao, L., Zhang, L., Yuan, X., and Zhao, B. (2016). Preparation, Phytochemical Investigation, and Safety Evaluation of Chlorogenic Acid Products from Eupatorium adenophorum. Molecules, 22.","DOI":"10.3390\/molecules22010067"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Amano, Y., Honda, H., Nukada, Y., Ikeda, N., Yamane, M., Nakano, K., Kameyama, A., and Morita, O. (2019). Safety Pharmacological Evaluation of the Coffee Component, Caffeoylquinic Acid, and Its Metabolites, Using Ex Vivo and In Vitro Profiling Assays. Pharmaceuticals, 12.","DOI":"10.3390\/ph12030110"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"105109","DOI":"10.1016\/j.phrs.2020.105109","article-title":"New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily","volume":"161","author":"Song","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4274\/tjps.galenos.2019.92678","article-title":"Safety Assessment of Vanillic Acid: Subacute Oral Toxicity Studies in Wistar Rats","volume":"17","author":"Mirza","year":"2020","journal-title":"Turk. J. Pharm. Sci."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tifs.2022.02.023","article-title":"Discovering multifaceted role of vanillic acid beyond flavours: Nutraceutical and therapeutic potential","volume":"122","author":"Kaur","year":"2022","journal-title":"Trends Food Sci. Technol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Truzzi, F., Valerii, M.C., Tibaldi, C., Zhang, Y., Abduazizova, V., Spisni, E., and Dinelli, G. (2020). Are Supplements Safe? Effects of Gallic and Ferulic Acids on In Vitro Cell Models. Nutrients, 12.","DOI":"10.3390\/nu12061591"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2478\/v10102-011-0027-5","article-title":"Toxicological aspects of the use of phenolic compounds in disease prevention","volume":"4","author":"Kyselova","year":"2011","journal-title":"Interdiscip. Toxicol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12937-016-0217-2","article-title":"An overview on the role of dietary phenolics for the treatment of cancers","volume":"15","author":"Anantharaju","year":"2016","journal-title":"Nutr. J."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Saleem, A., Akhtar, M.F., Sharif, A., Akhtar, B., Siddique, R., Ashraf, G.M., Alghamdi, B.S., and Alharthy, S.A. (2022). Anticancer, Cardio-Protective and Anti-Inflammatory Potential of Natural-Sources-Derived Phenolic Acids. Molecules, 27.","DOI":"10.3390\/molecules27217286"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Ma, Z., Huang, Z., Zhang, L., Li, X., Xu, B., Xiao, Y., Shi, X., Zhang, H., Liao, T., and Wang, P. (2020). Vanillic Acid Reduces Pain-Related Behavior in Knee Osteoarthritis Rats Through the Inhibition of NLRP3 Inflammasome-Related Synovitis. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.599022"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"854015","DOI":"10.1155\/2015\/854015","article-title":"Interactions between CYP3A4 and Dietary Polyphenols","volume":"2015","author":"Basheer","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"bqaa134","DOI":"10.1210\/endocr\/bqaa134","article-title":"NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment","volume":"161","author":"DiStefano","year":"2020","journal-title":"Endocrinology"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/7\/760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:55:36Z","timestamp":1760032536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/7\/760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":220,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["antiox14070760"],"URL":"https:\/\/doi.org\/10.3390\/antiox14070760","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}